Paolo Ferrari
Department of Nephrology and Hypertension
University of Berne
Switzerland
Name/email consistency: high
- Genetics of the mineralocorticoid system in primary hypertension. Ferrari, P. Curr. Hypertens. Rep. (2002)
- Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade. Ferrari, P., Marti, H.P., Pfister, M., Frey, F.J. J. Hypertens. (2002)
- Modulation of renal calcium handling by 11 beta-hydroxysteroid dehydrogenase type 2. Ferrari, P., Bianchetti, M.G., Sansonnens, A., Frey, F.J. J. Am. Soc. Nephrol. (2002)
- Juvenile hypertension, the role of genetically altered steroid metabolism. Ferrari, P., Bianchetti, M., Frey, F.J. Horm. Res. (2001)
- In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice. Ferrari, P., Sansonnens, A., Dick, B., Frey, F.J. Hypertension (2001)
- The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. Ferrari, P., Lovati, E., Frey, F.J. J. Hypertens. (2000)
- Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation. Ferrari, P., Krozowski, Z. Kidney Int. (2000)
- Abnormalities in insulin sensitivity, vascular resistance and erythrocyte cation transport are independent genetic traits in familial hypertension. Ferrari, P., Siccoli, M.M., Fontana, M.J., Bianchetti, M.G. Blood Press. (1999)